Edwin Abel, MD
Urology · Madison, WINPI 1083800510
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,044 of the $22,267 with a category attached, or 94.5%. 3 manufacturers reported payments, led by Medical Device Business Services, Inc. at 51.0% of the total. Among urology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 6 payments — averaging $3711.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$11K
- Johnson & Johnson$9K
- Sanofi$2K
Across 4 payments — averaging $39,275 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ethicon Endo-surgery Inc.$99K
- Histosonics, Inc.$58K
What the payments were for
- Consulting fees$21,04495%
- Travel & lodging$1,2235%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $11,348 |
| Johnson & Johnson | 1 | $8,775 |
| Sanofi | 1 | $2,144 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Certus 140$18,900
- JEVTANA$2,144
- Neuwave$1,223
How this compares
$22,267 in reported general payments places this provider in the 95th percentile of 215 urology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Alfuzosin Hcl ErAlfuzosin Hcl | 13 | $108 |
Paid to pharmacies, not to this prescriber.
Other urology in Madison
- Dan GralnekMadison$142K
- Christopher ManakasMadison$87K
- Javier SantiagoMadison$57K
- Margaret KnoedlerMadison$31K
- Stephen NakadaMadison$11K
- Kyle RichardsMadison$9K
- Reginald BruskewitzMadison$8K
- Sara BestMadison$7K
- Daniel RoadmanMadison$5K
- Ali AntarMadison$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.